US Broker Ratings

Baxter International (BAX) Investor Outlook: 22% Upside Potential Amid Mixed Valuation Metrics

Baxter International Inc. (NYSE: BAX), a stalwart in the healthcare sector specializing in medical instruments and supplies, is positioned at an intriguing juncture for investors. With..

GSK plc (GSK) Stock Analysis: Unveiling a 26% Potential Upside in the Healthcare Sector

GSK plc (NYSE: GSK), a leading player in the healthcare sector, is positioned in the drug manufacturing industry with a robust market capitalization of $94.23 billion...

DaVita Inc. (DVA) Stock Analysis: Uncovering a 23% Potential Upside in the Healthcare Sector

DaVita Inc. (NYSE: DVA), a leader in the healthcare sector specializing in kidney dialysis services, has been attracting attention from investors due to its significant potential..

Humana Inc. (HUM) Stock Analysis: Navigating Growth with a Potential 9.11% Upside

Humana Inc. (HUM), a prominent player in the healthcare sector, has been making waves with its comprehensive range of insurance and health services. With a market..

ResMed Inc. (RMD) Stock Analysis: Assessing a Potential 14% Upside in the Healthcare Sector

ResMed Inc. (NYSE: RMD), a prominent player in the healthcare sector, particularly in the field of medical instruments and supplies, is garnering attention due to its..

Edwards Lifesciences Corporation (EW) Investor Outlook: A Promising 18.57% Upside in the Medical Devices Sector

Edwards Lifesciences Corporation (NYSE: EW), a titan in the healthcare sector with a commanding $49.03 billion market capitalization, continues to capture investor interest with its innovative..

Genmab A/S (GMAB) Stock Analysis: Exploring a 15% Potential Upside in Biotechnology

Genmab A/S (GMAB), a prominent player in the biotechnology sector, continues to capture investor interest with its robust pipeline of antibody-based treatments and strategic collaborations. Headquartered..

BeOne Medicines Ltd. (ONC) Stock Analysis: A Promising 21% Upside in the Biotech Sector

BeOne Medicines Ltd. (ONC), a prominent player in the biotechnology sector, is making waves among investors with a compelling growth narrative. Headquartered in Basel, Switzerland, the..

IDEXX Laboratories, Inc. (IDXX) Stock Analysis: Robust Growth Potential with a 35% Upside

IDEXX Laboratories, Inc. (NASDAQ: IDXX), a prominent player in the healthcare sector, specifically within the diagnostics and research industry, presents a compelling investment opportunity. With a..

Amgen Inc. (AMGN) Stock Analysis: Navigating a Robust Healthcare Giant with a 2.50% Dividend Yield

Amgen Inc. (NASDAQ: AMGN), a stalwart in the healthcare sector, continues to captivate investors with its strong market presence and innovative therapeutic solutions. With a market..

The Cooper Companies, Inc. (COO): Investor Outlook Highlights 16% Potential Upside

The Cooper Companies, Inc. (NYSE: COO), a prominent player in the healthcare sector, stands at a crossroads of potential growth and stability, offering a compelling proposition..

McKesson Corporation (MCK) Stock Analysis: Navigating Growth with an 8.54% Upside Potential

As a titan in the healthcare sector, McKesson Corporation (NYSE: MCK) stands as a pivotal player in medical distribution. With a robust market capitalization of $105.2..

Teva Pharmaceutical Industries (TEVA) Stock Analysis: Targeted Growth with a 15% Upside Potential

Teva Pharmaceutical Industries Limited (NYSE: TEVA), headquartered in Tel Aviv-Yafo, Israel, stands as a key player in the healthcare sector, specifically within the drug manufacturers’ specialty..

Insulet Corporation (PODD) Stock Analysis: Assessing a 30% Upside in the Medical Device Sector

Insulet Corporation (NASDAQ: PODD) stands out in the healthcare sector, particularly within the dynamic medical devices industry, as a compelling opportunity for investors seeking exposure to..

IQVIA Holdings, Inc. (IQV) Stock Analysis: A Healthcare Powerhouse with 11.82% Potential Upside

IQVIA Holdings, Inc. (NYSE: IQV), a leader in the healthcare diagnostics and research industry, presents a compelling case for investors seeking growth in the sector. With..

Centene Corporation (CNC) Stock Analysis: Evaluating a 13.95% Upside Potential in the Healthcare Sector

Centene Corporation (NYSE: CNC) stands as a formidable player in the healthcare plans industry, offering managed care services across diverse segments such as Medicaid, Medicare, and..

Koninklijke Philips N.V. (PHG) Stock Analysis: A 34.32% Upside Potential in the Healthcare Sector

Investors eyeing opportunities in the healthcare sector may want to take a closer look at Koninklijke Philips N.V. (NYSE: PHG), a leading name in the medical..

Pfizer, Inc. (PFE) Stock Analysis: A Healthcare Giant with a Robust 6.19% Dividend Yield and Strategic Collaborations

Pfizer Inc. (NYSE: PFE), a cornerstone in the healthcare sector, continues to capture investor attention with its impressive dividend yield and strategic partnerships. As a leading..

Royalty Pharma plc (RPRX) Stock Analysis: Exploring a 13.93% Potential Upside

Royalty Pharma plc (NASDAQ: RPRX) stands out in the biopharmaceutical sector as a unique entity specializing in the acquisition of royalties and funding innovation. With a..

argenx SE (ARGX) Stock Analysis: Biotechnology Leader with 28.40% Potential Upside

argenx SE (NASDAQ: ARGX), a prominent player in the biotechnology sector, has captured investor attention with its robust pipeline and impressive market cap of $57.51 billion...

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds